Have a feature idea you'd love to see implemented?
Let us know!
BCYC BICYCLE THERAPEUTICS plc
Price (delayed)
$24.58
Market cap
$1.7B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.78
Enterprise value
$772.13M
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short
Highlights
BICYCLE THERAPEUTICS's quick ratio has surged by 163% YoY and by 45% QoQ
BCYC's equity has surged by 145% since the previous quarter
BICYCLE THERAPEUTICS's gross profit has surged by 76% YoY but it has decreased by 4.9% QoQ
BCYC's revenue has soared by 76% YoY but it is down by 4.9% QoQ
BCYC's net income is down by 18% YoY
Key stats
What are the main financial stats of BCYC
Market
Valuations
Earnings
Shares outstanding
68.99M
Market cap
$1.7B
Enterprise value
$772.13M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.2
Price to sales (P/S)
32.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.51
Revenue
$39.57M
EBIT
-$159.74M
EBITDA
-$153.09M
Free cash flow
-$164.79M
Per share
Balance sheet
Liquidity
EPS
-$3.78
Free cash flow per share
-$3.17
Book value per share
$20.43
Revenue per share
$0.76
TBVPS
$20.34
Total assets
$1.06B
Total liabilities
$183.54M
Debt
$37.64M
Equity
$873.81M
Working capital
$958.65M
Debt to equity
0.04
Current ratio
14.77
Quick ratio
14.48
Net debt/EBITDA
6.03
Margins
Efficiency
Dividend
EBITDA margin
-386.9%
Gross margin
100%
Net margin
-417.9%
Operating margin
-463.4%
Return on assets
-23.3%
Return on equity
-32.8%
Return on invested capital
-289.3%
Return on capital employed
-16.2%
Return on sales
-403.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BCYC stock price
How has the BICYCLE THERAPEUTICS stock price performed over time
Intraday
4.46%
1 week
8.95%
1 month
-6.75%
1 year
14.22%
YTD
35.95%
QTD
8.62%
Financial performance
How have BICYCLE THERAPEUTICS's revenue and profit performed over time
Revenue
$39.57M
Gross profit
$39.57M
Operating income
-$183.4M
Net income
-$165.37M
Gross margin
100%
Net margin
-417.9%
BICYCLE THERAPEUTICS's gross profit has surged by 76% YoY but it has decreased by 4.9% QoQ
BCYC's revenue has soared by 76% YoY but it is down by 4.9% QoQ
BCYC's net margin is up by 33% year-on-year but it is down by 3.4% since the previous quarter
The operating margin has grown by 29% YoY but it has contracted by 7% from the previous quarter
Growth
What is BICYCLE THERAPEUTICS's growth rate over time
Valuation
What is BICYCLE THERAPEUTICS stock price valuation
P/E
N/A
P/B
1.2
P/S
32.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.51
BICYCLE THERAPEUTICS's EPS has increased by 19% YoY and by 14% from the previous quarter
BCYC's equity has surged by 145% since the previous quarter
The stock's P/B is 64% below its 5-year quarterly average of 3.3 and 40% below its last 4 quarters average of 2.0
BCYC's revenue has soared by 76% YoY but it is down by 4.9% QoQ
The P/S is 31% less than the 5-year quarterly average of 46.9 but 20% more than the last 4 quarters average of 27.0
Efficiency
How efficient is BICYCLE THERAPEUTICS business performance
The company's return on invested capital has shrunk by 70% YoY and by 7% QoQ
The ROE has grown by 40% YoY and by 33% from the previous quarter
BICYCLE THERAPEUTICS's ROS has increased by 34% YoY but it has decreased by 2.9% from the previous quarter
The ROA has grown by 29% YoY and by 23% from the previous quarter
Dividends
What is BCYC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BCYC.
Financial health
How did BICYCLE THERAPEUTICS financials performed over time
BICYCLE THERAPEUTICS's quick ratio has surged by 163% YoY and by 45% QoQ
BCYC's current ratio has surged by 161% year-on-year and by 42% since the previous quarter
BCYC's debt is 96% smaller than its equity
BCYC's equity has surged by 145% since the previous quarter
BICYCLE THERAPEUTICS's debt to equity has plunged by 79% YoY and by 64% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.